Related Experiment Video
Updated: Aug 11, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
Stability of cyanocobalamin in parenteral preparations
1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Karachi, Karachi-75270, Pakistan.
Abstract:
The stability of seven commercial parenteral preparations of cyanocobalamin (vitamin B(12)) on storage under normal laboratory conditions for a period of twelve months has been studied using a two component spectrophotometric method for the simultaneous determination of cyanocobalamin and the degradation product, hydroxocobalamin, at 550 and 525 nm. The single ingredient vitamin B(12) preparations have been found to be stable and the potency lies within the B.P. limits. In multi-ingredient (B(1) + B(6) + B(12)) preparations cyanocobalamin is unstable and degrades from 28% to 37% with concomitant formation of hydroxocobalamin (1.7% to 25.5%) and oxidation products amounting to 56.4% +/- 9.3. Thus more than half of the vitamin content is lost during storage and these preparations are not suitable for parenteral use.
More Related Videos
Related Concept Videos
Steady State Concentration
Most drugs are administered in repeated doses at fixed intervals or through continuous intravenous...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Drug Product Stability
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Modified-Release Drug Delivery Systems: Bioavailability

